Latest / Morning Medical with Dr. Chow / Foundayo Approval, Wildfires' Impact, and Cardiovascular Health Insights

Transcript

Foundayo Approval, Wildfires' Impact, and Cardiovascular Health Insights · Morning Medical with Dr. Chow

• 0:00
  Hello and welcome to Morning Medical with Dr.
• 0:02
  Chow, your daily dose of the most recent medical and health news from around the globe,
• 0:08
  all brought to you with the help of artificial intelligence.
• 0:11
  I'm Dr.
• 0:12
  Chi-Ming Chow, and today, we're diving into some intriguing developments in the world of
• 0:17
  medicine.
• 0:18
  Let's kick things off with some exciting news from the United Kingdom.
• 0:24
  A new daily weight-loss pill called Foundayo has been approved for use in the United
• 0:29
  Kingdom, marking the first approval of its kind in Europe.
• 0:33
  This pill is produced by Eli Lilly, the pharmaceutical company also behind the Mounjaro
• 0:39
  jab.
• 0:40
  Foundayo is designed to treat obesity and type 2 diabetes, and while it's available privately
• 0:46
  with a prescription, it's not yet automatically available on the National Health Service.
• 0:52
  Approval by the Medicines and Healthcare products Regulatory Agency doesn't guarantee
• 0:58
  that it'll be provided by the NHS, but it can be used immediately for managing type 2
• 1:03
  diabetes.
• 1:05
  Foundayo is a type of GLP-1 medication, which works by suppressing appetite.
• 1:11
  This approval follows the recent nod to a similar weight-loss drug, Wegovy, back in June.
• 1:17
  Eli Lilly plans to apply to the National Institute for Health and Care Excellence in
• 1:21
  England to have it recommended as a weight-loss treatment.
• 1:24
  While the weight-loss benefits of Foundayo might not match some other treatments, Dr.
• 1:30
  Simon Cork from Anglia Ruskin University mentions that patients can still expect
• 1:35
  significant and clinically meaningful weight changes.
• 1:39
  Moreover, Foundayo is potentially more affordable than other treatments, which have
• 1:44
  often been limited in availability through the NHS.
• 1:48
  Professor Naveed Sattar from the University of Glasgow also sees this as a positive
• 1:52
  development, noting that the convenience of Foundayo is a significant advantage.
• 1:58
  Unlike the Wegovy pill, which needs to be taken on an empty stomach, Foundayo can be taken at
• 2:04
  any time of the day, making it a more flexible option for patients.
• 2:08
  This new oral option is expected to help more people find a treatment that aligns with their
• 2:13
  needs and preferences.
• 2:16
  An interesting aspect of Foundayo is its potential to aid individuals transitioning off
• 2:21
  weight-loss injections.
• 2:24
  Trials have shown that patients who switched from weight-loss jabs to the daily tablet,
• 2:28
  known as orforglipron, maintained much of their weight loss over a year, avoiding the common
• 2:34
  issue of regaining weight after stopping GLP-1 injections.
• 2:38
  Of course, as with any medication, there are possible side effects to consider.
• 2:43
  Users of Foundayo may experience nausea, diarrhea, constipation, and vomiting.
• 2:50
  Patients are also advised to maintain a healthy diet and exercise regularly to maximize their
• 2:56
  results.
• 2:59
  In British Columbia, Canada, an alarming situation has unfolded as the province declares
• 3:04
  a state of emergency due to fast-moving wildfires.
• 3:08
  The entire community of Summerland was recently ordered to evacuate when the Bald Range
• 3:13
  wildfire expanded rapidly.
• 3:15
  This fire, situated between Summerland and Peachland, has been a significant concern as
• 3:20
  high temperatures and strong winds have exacerbated wildfire risks across the region.
• 3:26
  As of Monday, the situation remains critical, with the wildfires causing displacement of
• 3:32
  thousands of individuals throughout the province.
• 3:35
  The fire danger is assessed based on several factors, such as weather conditions, the fire's
• 3:40
  location, and available fuels that could potentially intensify the fire.
• 3:45
  This assessment aids authorities in effectively allocating resources to combat the blaze.
• 3:51
  The current wildfires have not only affected British Columbia but have also prompted
• 3:56
  air-quality warnings across vast areas of Canada, with smoke traveling thousands of
• 4:02
  kilometers from active fire zones.
• 4:05
  Health Canada has issued warnings as the smoke from these wildfires has even reached the
• 4:10
  United States, propelled by strong winds.
• 4:13
  The Air Quality Health Index, a tool that helps understand the health implications of air
• 4:19
  quality levels, indicates a high risk when it reaches seven or higher on a ten-plus point
• 4:24
  scale.
• 4:25
  When air quality is deemed high risk, people are advised to limit or adjust outdoor
• 4:30
  activities, particularly if symptoms like coughing develop.
• 4:35
  Vulnerable groups, including individuals aged sixty-five or older, young children, and those
• 4:40
  with pre-existing health conditions such as lung or heart issues, are particularly urged to
• 4:47
  be cautious.
• 4:48
  As wildfires continue to rage out of control, the Canadian Wildland Fire Information System
• 4:54
  provides data on the hectares burned.
• 4:57
  The statistics show an alarming amount of land affected by these fires, with the cumulative
• 5:02
  hectares burned reaching significant figures this year.
• 5:06
  This ongoing crisis highlights the need for increased preparedness and resource allocation
• 5:11
  to mitigate the devastating effects of wildfires on communities and the environment.
• 5:18
  A recent study conducted by New York University Langone Health has revealed that middle-aged
• 5:23
  adults who successfully avoid high blood pressure, diabetes, and smoking can gain nearly
• 5:28
  thirteen additional years of life free from dementia.
• 5:32
  This research, published in the journal Neurology Open Access, delved into long-term
• 5:37
  health data to understand how cardiovascular wellness during midlife can influence brain
• 5:42
  function in later years.
• 5:44
  According to Dr.
• 5:46
  Josef Coresh, the study’s senior investigator and founding director of the Optimal Aging
• 5:52
  Institute at New York University Langone, these findings underscore the importance of actively
• 5:58
  avoiding these risk factors in midlife as a strategy to preserve brain health for over a
• 6:04
  decade.
• 6:05
  It is crucial, he notes, because approximately forty-two percent of Americans are projected to
• 6:10
  develop dementia after the age of fifty-five.
• 6:14
  The study analyzed data from the Atherosclerosis Risk in Communities study, an
• 6:20
  ongoing project that began in nineteen eighty-six.
• 6:23
  It included more than twelve thousand dementia-free participants, with an average age
• 6:28
  of fifty-six.
• 6:29
  Researchers tracked the participants' health trajectories for about twenty-six years,
• 6:34
  focusing on their smoking habits, blood pressure, and diabetes status.
• 6:40
  By the end of the study, three thousand eight participants had developed dementia, while five
• 6:45
  thousand two hundred thirty-eight passed away without cognitive impairment.
• 6:51
  The results showed a stark difference based on midlife health: those who avoided all three
• 6:56
  risk factors averaged thirty dementia-free years after their baseline exams, compared to
• 7:02
  just seventeen years for those with all three conditions.
• 7:06
  The study also highlighted demographic trends across sex and race.
• 7:11
  Female participants generally enjoyed longer periods of cognitive health than their male
• 7:15
  counterparts, regardless of health risks.
• 7:19
  Women with all three risk factors survived an average of eighteen point one years without
• 7:24
  dementia, compared to sixteen point six years for men.
• 7:29
  White participants with all three risk factors had an average of nineteen point six
• 7:33
  dementia-free years, while Black participants averaged sixteen years.
• 7:39
  These findings suggest that while vascular risk reduction can benefit all groups, certain
• 7:44
  populations, particularly Black adults, may gain more from targeted prevention efforts.
• 7:51
  Dr.
• 7:52
  Coresh hopes that this data will inspire people to quit smoking and begin monitoring their
• 7:56
  cardiovascular health starting in their late forties.
• 8:00
  It is important to note that the observational nature of the study means it cannot prove
• 8:05
  direct cause and effect.
• 8:08
  Additionally, health status was recorded during a single visit, and some potential midlife
• 8:14
  lifestyle changes were not reported.
• 8:18
  Despite these limitations, the study provides valuable insights into how maintaining
• 8:23
  cardiovascular health in midlife can significantly delay the onset of dementia,
• 8:29
  encouraging individuals to adopt healthier lifestyles.
• 8:34
  In a recent study conducted in China, researchers have uncovered a fascinating yet
• 8:39
  concerning link between pet hamsters and a rare brain disorder known as autoimmune cerebellar
• 8:46
  ataxia.
• 8:47
  This disorder, characterized by symptoms such as rapid onset of double vision, slurred
• 8:53
  speech, and coordination issues, was found to have a significant association with exposure to
• 8:59
  pet hamsters.
• 9:01
  The study, led by Dr.
• 9:03
  Hongzhi Guan from the Chinese Academy of Medical Sciences and Peking Union Medical
• 9:08
  College, was published in the Journal of Neurology, Neurosurgery & Psychiatry.
• 9:14
  The research involved a hospital-based case-control study where patients with
• 9:18
  autoimmune cerebellar ataxia were compared to a control group with other autoimmune central
• 9:23
  nervous system disorders.
• 9:25
  Astonishingly, 56.1% of those with autoimmune cerebellar ataxia had been exposed to hamsters,
• 9:32
  a stark contrast to just 4.5% in the control group.
• 9:36
  This suggests a strong correlation between hamster exposure and the development of this
• 9:41
  rare brain disorder, a relationship not observed with other common household pets like
• 9:45
  dogs and cats.
• 9:47
  Among the patients studied, those with hamster exposure showed distinctive neurological signs
• 9:53
  and inflammatory markers in their cerebrospinal fluid.
• 9:57
  This includes higher counts of white blood cells and protein concentrations, as well as a
• 10:03
  higher prevalence of oligoclonal bands, which are indicative of autoimmune activity.
• 10:09
  Interestingly, the study noted that all patients tested negative for cerebrospinal
• 10:14
  fluid pathogens, further suggesting an autoimmune rather than infectious origin for
• 10:19
  the disorder.
• 10:21
  The researchers hypothesize that hamsters might trigger abnormal autoimmune responses through
• 10:27
  mechanisms that remain unidentified.
• 10:30
  This could be akin to other neuroimmune diseases where pathogens or certain triggers
• 10:36
  lead to immune system dysregulation.
• 10:40
  The study draws parallels with conditions like Guillain-Barré syndrome, where similar immune
• 10:45
  responses are observed.
• 10:47
  Dr.
• 10:48
  Andrew McKeon from the Mayo Clinic, who was not involved with the study, emphasized the
• 10:53
  importance of identifying such risk factors, noting that autoimmune cerebellar ataxia can
• 10:59
  have variable prognoses.
• 11:02
  He highlighted that autoantibodies detected in serum or cerebrospinal fluid can aid in
• 11:08
  diagnosing this condition, and a history of non-neurological autoimmune disease can
• 11:12
  increase risk.
• 11:14
  While the study provides compelling insights, it does come with limitations, including its
• 11:19
  small sample size and the retrospective nature of hamster exposure assessment.
• 11:24
  Nonetheless, these findings open up new avenues for understanding autoimmune cerebellar ataxia
• 11:30
  and highlight the potential need for caution among hamster owners.
• 11:35
  In today's episode, we're turning our attention to a significant issue affecting older adults
• 11:41
  with type 2 diabetes.
• 11:44
  A recent review of electronic health records has revealed that many older adults with type 2
• 11:49
  diabetes are not receiving the recommended adjustments to their medication regimens,
• 11:54
  especially when their hemoglobin A1c levels fall outside the target goals set by the
• 11:59
  American Diabetes Association.
• 12:03
  The study, led by Dr.
• 12:04
  Phuc Le from the Cleveland Clinic and published in JAMA Internal Medicine, analyzed the records
• 12:11
  of nearly ninety thousand patients aged sixty-five and older.
• 12:16
  It found that only sixteen point nine percent of those with hemoglobin A1c levels below the
• 12:22
  recommended goals received a deintensification of their medication regimen.
• 12:27
  Conversely, only thirty-two point eight percent of patients with above-goal hemoglobin A1c
• 12:33
  levels had their treatment intensified.
• 12:37
  This lack of adjustment is concerning, as it represents a missed opportunity to align
• 12:42
  treatment intensity with individual patient needs.
• 12:46
  Dr.
• 12:47
  Le emphasized the importance of tailoring hemoglobin A1c goals to a patient's overall
• 12:53
  health status.
• 12:54
  For instance, patients with significant cognitive or functional limitations, frailty,
• 13:00
  or severe comorbidities should follow less stringent targets to avoid the risks associated
• 13:06
  with overly intensive glycemic control, such as hypoglycemia.
• 13:11
  On the other hand, healthier patients with longer life expectancies can benefit from a
• 13:16
  more intensive regimen, with goals similar to those for younger adults.
• 13:20
  Clinicians are encouraged to consider a patient's health, comorbidities, functional
• 13:25
  status, life expectancy, and treatment preferences when setting glycemic goals.
• 13:31
  This approach ensures that the medication regimen remains appropriate and beneficial for
• 13:36
  each individual.
• 13:38
  The study highlighted that across the study period, there was a significant portion of
• 13:43
  patients who did not receive appropriate medication adjustments.
• 13:47
  Among the participants, seven point nine percent were in good health, sixty-one point
• 13:53
  six percent had intermediate health, and thirty point six percent had poor health status.
• 13:59
  Despite these variations in health status, the adjustments in medication did not consistently
• 14:04
  reflect the patients' needs.
• 14:07
  The researchers found that patients with above-goal hemoglobin A1c were more likely to
• 14:13
  experience medication intensification compared to those at-goal.
• 14:18
  However, this pattern was similar across all health statuses, including among healthy older
• 14:23
  adults.
• 14:24
  This underlines a gap in glycemic control, especially in otherwise healthy older adults
• 14:29
  who are at risk for long-term complications like retinopathy, nephropathy, and
• 14:34
  cardiovascular disease.
• 14:37
  Conversely, those with below-goal hemoglobin A1c had a similar rate of deintensification
• 14:44
  compared to at-goal patients and a lower rate of intensification.
• 14:49
  This was particularly concerning for patients with poor health, as intensive glycemic control
• 14:54
  in frail or medically complex older adults is associated with increased risks of hypoglycemia
• 15:00
  and other adverse outcomes.
• 15:03
  Dr.
• 15:04
  Le stressed that deintensification should not be viewed as providing less care.
• 15:11
  In fact, safely reducing medication burden can be an important aspect of good diabetes care
• 15:17
  for some older adults.
• 15:19
  The goal is to balance the long-term benefits of glycemic control against treatment burden
• 15:25
  and potential adverse effects, especially in patients with substantial comorbidity or
• 15:30
  limited life expectancy.
• 15:33
  The study could not determine why individual clinicians made the decisions they did
• 15:37
  regarding medication adjustments.
• 15:40
  However, the findings highlight the need for clinicians to make individualized glycemic
• 15:44
  goals a more explicit part of clinical decision-making.
• 15:48
  The authors recommend focusing on improving adherence to guideline recommendations and
• 15:53
  leveraging safer medication options for this population.
• 15:58
  As we wrap up today's episode, it's clear that there's a critical need for more personalized
• 16:03
  diabetes care, particularly for older adults.
• 16:07
  By aligning treatment with individual health needs, we can improve outcomes and enhance the
• 16:13
  quality of life for those living with type 2 diabetes.
• 16:17
  Thank you for joining me today on Morning Medical with Dr.
• 16:21
  Chow.
• 16:22
  Until next time, stay informed and stay healthy.